HIV/AIDS: Drug Therapy
Dr. Alexandra Levine, Chief of the Division of Hematology at the USC School of Medicine, talks about the drugs that have been used in the fight against HIV/AIDS since AZT was developed in 1987. She also explains that the high cost of the drugs makes...
HIV/AIDS: Drug Therapy Side Effects and Complications
Dr. Alexandra Levine, Chief of the Division of Hematology at the USC School of Medicine, explains that the cocktails of drugs used to fight HIV/AIDS can be very effective, but can also be complicated to take properly and cause serious side effects. ...
Transcript: them And i am afraid that we may be seeing another epidemic Of resistant viruses getting out in the world. The drugs are also difficult because they have
HIV/AIDS: Blood Supply Safety
Dr. Alexandra Levine, Chief of the Division of Hematology at the USC School of Medicine, talks about the strides that have been made in making sure the blood supply in the United States is safe in the wake of the HIV/AIDS pandemic. Although there is...
HIV/AIDS: A Clinical Description
Dr. Alexandra Levine, Chief of the Division of Hematology at the USC School of Medicine, talks about the medical realities of HIV/AIDS, explaining the progression of the disease, as well as the symptoms (or lack of symptoms) at various stages along ...
Transcript: viruses or germs can actually cause cancer. And if you, as an example, are infected By something called hpv, human papillomavirus That can cause cervical
Fighting HIV/AIDS in the Future
Dr. Alexandra Levine, Chief of the Division of Hematology at the USC School of Medicine, talks about carrying the fight against HIV/AIDS into the future. Dr. Levine observes that, in the years ahead, there will be drugs developed that will be able t...
Protection Against HIV/AIDS
Dr. Alexandra Levine, Chief of the Division of Hematology at the USC School of Medicine, talks about the things people can do to protect themselves from contracting HIV. Some of these include knowing the sexual history of one's partner and making su...